Home

Where clinician-in-the-loop
meets agentic AI

The Problem: Today’s drug development and portfolio decisions depend on a manual process—searching fragmented sources, collecting information into spreadsheets, interpreting, and synthesizing it by hand to inform high-stakes decisions.

The Result: Wasted time, missed milestones, decision delays, exposure to risk, misallocated capital, and outright drug failures.

The Solution: KARITHERA is a precedent-driven engine for pharma professionals, combining deep regulatory expertise with in-depth clinical and commercial judgment. Powered by KARI—an agentic AI assistant built with clinician-in-the-Loop — KARITHERA understands the nuance and context of drug development and investment decisions. The result is fast, defensible, and trusted intelligence, delivering the clarity, speed, and impact required for high-stakes decisions.

Compare trials across ALS, Compare labels in ALS

Try another prompt
Ask KARI

Leveraging precedent for confident drug
development decisions

  • The Intelligence Gap: Drug development decisions depend on regulatory and clinical precedent. Yet the intelligence behind those decisions remains fragmented across FDA and EMA archives, trial registries, labels, and scattered public sources. Teams spend valuable time piecing together what should already be structured. This fragmentation delays strategy, clouds portfolio choices, and increases capital risk. High-stakes decisions require structured intelligence, not document retrieval.
  • The KARITHERA Platform: KARITHERA converts fragmented data into structured strategic insight. It unifies regulatory decisions, clinical trials, labeling history, clinical reviews, advisory committees and combined reports within a single queryable environment. KARITHERA provides comparison across approvals, endpoints, development paths, and regulatory opinion and logic. KARI is Not a chatbot, or just a document archive. KARI is an intelligence layer built to support consequential decisions.

KARITHERA Enables

  • Evaluation of trial design against historical approvals.
  • Analysis of labeling evolution across markets.
  • Identification of regulatory inflection points.
  • Definition of competitive positioning with precision.
  • Pressure-testing of portfolio strategy.
  • Investment diligence grounded in structured evidence.
  • From question to conviction within minutes.

Designed for Leaders in

  • Clinical development.
  • Regulatory strategy.
  • Medical and commercial planning.
  • Portfolio and BD governance.
  • Life science investment.
  • KARITHERA supports those accountable for all outcomes.

See KARITHERA in action

Watch how teams use KARITHERA to make faster, more confident decisions.

Built to deliver CLARITY, SPEED & IMPACT
in drug development

KARITHERA is a cloud-native intelligence platform designed to help lifescience drug development professionals move faster with confidence. Powered by proprietary, multi-LLM architecture, KARITHERA delivers instant access to curated, validated pharmaceutical intelligence through KARI, your pharma-native AI assistant.

Fully Automated Data Ingestion

Enterprise-grade, Azure-hosted AI continuously ingests and updates data — ensuring recency, scalability, and security at all times.

Curated, Trusted Data Sources with clinician-in-the-loop

Our continuously updated data platform, curated by clinical & regulatory experts, integrates trusted sources across drug development, including clinical trials, regulatory documents,
prescribing labels, etc.

KARI: Your intelligent AI assistant

KARI, our easy-to-use AI assistant, has been pre-trained by clinical and regulatory experts, to understand pharma and medical context, terminology, and workflows—providing precise and trusted, answers on demand.

Scroll to Top